Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavitySPRUANCE, S. L.Journal of clinical microbiology (Print). 1984, Vol 19, Num 5, pp 675-679, issn 0095-1137Article

Pathogenesis of herpes simplex labialis: experimental induction of lesions with UV lightSPRUANCE, S. L.Journal of clinical microbiology (Print). 1985, Vol 22, Num 3, pp 366-368, issn 0095-1137Article

Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialisSPRUANCE, S. L.Journal of medical virology. 1993, pp 27-32, issn 0146-6615, SUP1Conference Paper

Pathogenesis of recurrent herpes simplex labialis. IV: Maturation of lesions within 8 hours after onset and implications for antiviral treatmentSPRUANCE, S. L; WENERSTROM, G.Oral surgery, oral medicine, oral pathology. 1984, Vol 58, Num 6, pp 667-671, issn 0030-4220Article

HSV sheddingSACKS, S. L; GRIFFITHS, P. D; WHITLEY, R. J et al.Antiviral research. Supplement. 2004, Vol 63, Num 1, pp S19-S26, issn 1380-6432Article

Tolerance and percutaneous absorption of topically applied arildoneBOSSO, J. A; SPRUANCE, S. L; WENERSTROM, G et al.Journal of clinical pharmacology. 1985, Vol 25, Num 2, pp 95-99, issn 0091-2700Article

Efficacy of topical treatment for herpes simplex infections: predictions from an index of drug characteristics in vitroFREEMAN, D. J; SPRUANCE, S. L.The Journal of infectious diseases. 1986, Vol 153, Num 1, pp 64-70, issn 0022-1899Article

Treatment of recurrent herpes simplex labialis with topical butylated hydroxytolueneFREEMAN, D. J; WENERSTROM, G; SPRUANCE, S. L et al.Clinical pharmacology and therapeutics. 1985, Vol 38, Num 1, pp 56-59, issn 0009-9236Article

Lessons from HIV and hepatitis virusesSACKS, S. L; GRIFFITHS, P. D; WHITLEY, R. J et al.Antiviral research. Supplement. 2004, Vol 63, Num 1, pp S11-S18, issn 1380-6432Article

Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised hostWHITLEY, R. J; SPRUANCE, S; HAYDEN, F. G et al.The Journal of infectious diseases. 1984, Vol 149, Num 1, pp 1-8, issn 0022-1899Article

Combination treatment with famciclovir and a topical corticosteroid Gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis : A pilot studySPRUANCE, S. L; MCKEOUGH, M. B.The Journal of infectious diseases. 2000, Vol 181, Num 6, pp 1906-1910, issn 0022-1899Article

HSV-2 transmissionSACKS, S. L; GRIFFITHS, P. D; WHITLEY, R. J et al.Antiviral research. Supplement. 2004, Vol 63, Num 1, pp S27-S35, issn 1380-6432Article

Imiquimod, a patient-applied immune-response modifier for treatment of external genital wartsBEUTNER, K. R; TYRING, S. K; TROFATTER, K. F et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 4, pp 789-794, issn 0066-4804Article

Acyclovir in human breast milkMEYER, L. J; DE MIRANDA, P; SHETH, N et al.American journal of obstetrics and gynecology. 1988, Vol 158, Num 3, pp 586-588, issn 0002-9378Article

Topical treatment of cutaneous herpes simplex virus infectionsSPRUANCE, S. L; FREEMAN, D. J.Antiviral research. 1990, Vol 14, Num 6, pp 305-321, issn 0166-3542, 17 p.Article

Evaluation of antiviral treatments for recurrent herpes simplex labialis in the dorsal cutaneous guinea pig modelSPRUANCE, S. L; MCKEOUGH, M. B.Antiviral research. 1988, Vol 9, Num 5, pp 295-313, issn 0166-3542Article

Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infectionSPRUANCE, S. L; FREEMAN, D. J; SHETH, N. V et al.Antimicrobial agents and chemotherapy. 1986, Vol 30, Num 1, pp 196-198, issn 0066-4804Article

Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infectionSPRUANCE, S. L; MCKEOUGH, M. B; CARDINAL, J. R et al.Antimicrobial agents and chemotherapy. 1984, Vol 25, Num 1, pp 10-15, issn 0066-4804Article

Recombinant human interferon-αA treatment of an experimental cutaneous herpes simplex virus type 1 infection of guinea pigsFREEMAN, D. J; MCKEOUGH, M. B; SPRUANCE, S. L et al.Journal of interferon research. 1987, Vol 7, Num 2, pp 213-222, issn 0197-8357Article

Immunostimulatory function of herpes simplex virusisolates from patients with frequent herpes labialis and a deficiency in immunespecific interferon productionKLIEMAN, R. L; GREEN, J. A; SPRUANCE, S. L et al.Journal of medical virology. 1985, Vol 16, Num 3, pp 289-296, issn 0146-6615Article

Measurement of the stratum corneum drug reservoir to predict the therapeutic efficacy of topical iododeoxyuridine for herpes simplex virus infectionSHETH, N. V; MCKEOUGH, M. B; SPRUANCE, S. L et al.Journal of investigative dermatology. 1987, Vol 89, Num 6, pp 598-602, issn 0022-202XArticle

Failure of topical acyclovir in ointment to penetrate human skinFREEMAN, D. J; SHETH, N. V; SPRUANCE, S. L et al.Antimicrobial agents and chemotherapy. 1986, Vol 29, Num 5, pp 730-732, issn 0066-4804Article

Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigsSPRUANCE, S. L; FREEMAN, D. J; SHETH, N. V et al.Antimicrobial agents and chemotherapy. 1985, Vol 28, Num 1, pp 103-106, issn 0066-4804Article

Preclinical studies of iododeoxuridine in dimethyl sulfoxide for the topical treatment of cutaneous herpes simplex virus infectionsFREEMAN, D. J; SHETH, N. V; SPRUANCE, S. L et al.International journal of pharmaceutics. 1988, Vol 48, Num 1-3, pp 141-147, issn 0378-5173Article

Spontaneous and induced interferon production by peripheral blood mononuclear leukocytes from humans with herpes labialisGREEN, J. A; WEISS, P. N; SPRUANCE, S. L et al.The Journal of immunology (1950). 1983, Vol 131, Num 6, pp 2827-2829, issn 0022-1767Article